CIPLA's weekly performance was lackluster, with a return of -0.06%, underperforming its peers. The stock's volatility was moderate at 15.77%, but its Sharpe Ratio of -0.02 indicates that the return was not sufficient to compensate for the risk taken. Compared to its peers, CIPLA lagged behind SUNPHARMA and DIVISLAB, but outperformed GRASIM. Overall, the stock was relatively risky this week, with a Max Drawdown of -1.16%.

[Volatility: 15.77%]